A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.

Philip M. Arlen, William L. Dahut, Catherine Parker et al.|Clinical Cancer Research|2006

Cited by 291